MERCK SHARP & DOHME CORP. v. FRESENIUS KABI USA, LLC > Summary
Court Case Number 3:14-cv-03917
Filing Date Jun 18, 2014
Court New Jersey District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
4Merck Sharp & Dohme
Attorney Name: William C. Baton
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: Amar A. Mehta
Paul Hastings
Merck Sharp & Dohme
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Defendant Attorneys
3Fresenius Kabi USA
Attorney Name: Arnold B. Calmann
Saiber
Fresenius Kabi USA
Attorney Name: Katherine A. Escanlar
Saiber
Fresenius Kabi USA
Attorney Name: Jeffrey Soos
Saiber
Counter Defendant
3Merck Sharp & Dohme
Attorney Name: William C. Baton
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Merck Sharp & Dohme
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Counter Claimant
3Fresenius Kabi USA
Attorney Name: Arnold B. Calmann
Saiber
Fresenius Kabi USA
Attorney Name: Katherine A. Escanlar
Saiber
Fresenius Kabi USA
Attorney Name: Jeffrey Soos
Saiber
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 05691336 | Morpholine compounds are prodrugs useful as tachykinin receptor antagonists | Nov 25, 1997 |
| 05070082 | Solubilized pro-drugs | Dec 3, 1991 |
| 04885380 | Process for preparing phosphonyloxyacyl amino acids and derivatives thereof | Dec 5, 1989 |
| 04748174 | Water soluble salts of an NSAID with meglumine/glucamine | May 31, 1988 |
